Oireachtas Joint and Select Committees

Thursday, 1 June 2017

Public Accounts Committee

2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability

9:00 am

Mr. Niall Cody:

The largest proportion of the money is claimed by the large multinationals because they are carrying out the most research and development in value terms, but the credit is probably more valuable proportionally to Enterprise Ireland-supported companies. We can give the committee a breakdown of the analysis and develop the piece of the paper from our corporation tax receipts, if that would be useful. The issue must be considered in its context. The credit is probably of greater proportional benefit to a small company carrying out research and development than it is to larger companies.

We work closely with the IDA and Enterprise Ireland on improving the guidance that we issue and simplifying the process. We have recently issued a briefing on research and development tax credit claims of a value up to €50,000 and simplified procedures to deal with the type of small company that is carrying out research and development that is small in total terms but significant from the point of view of those companies' success.

Comments

No comments

Log in or join to post a public comment.